Ligand validation:6CEX

NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose

NAG is a Ligand Of Interest in 6CEX designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6CEX_NAG_A_404	49%	72%	0.189	0.937	0.3	0.76	-	1	0	0	100%	0.9333
6CEX_NAG_A_403	48%	88%	0.167	0.909	0.16	0.5	-	-	0	0	100%	0.9333
6CEX_NAG_E_402	47%	85%	0.189	0.929	0.2	0.53	-	-	0	0	100%	0.9333
6CEX_NAG_E_403	43%	76%	0.191	0.913	0.25	0.7	-	1	0	0	100%	0.9333
6CEX_NAG_A_402	29%	76%	0.223	0.882	0.47	0.47	-	-	0	0	100%	0.9333
6CEX_NAG_E_411	23%	88%	0.236	0.86	0.25	0.41	-	-	0	0	100%	0.9333
6CEX_NAG_B_202	14%	83%	0.336	0.886	0.35	0.43	-	-	0	0	100%	0.9333
6CEX_NAG_F_202	13%	76%	0.36	0.899	0.3	0.63	-	1	1	0	100%	0.9333
3HMG_NAG_A_334	81%	39%	0.002	0.851	0.94	1.45	-	3	0	0	100%	0.9333
4HMG_NAG_E_334	81%	47%	0.074	0.924	0.7	1.34	-	1	0	0	100%	0.9333
5K9Q_NAG_F_201	76%	87%	0.08	0.916	0.2	0.49	-	-	0	0	100%	0.9333
2HMG_NAG_C_348	76%	52%	0.088	0.924	0.62	1.22	-	2	0	0	100%	0.9333
1HGD_NAG_E_334	72%	49%	0.085	0.908	0.8	1.17	-	2	0	0	100%	0.9333
3H0C_NAG_A_794	100%	56%	0.021	0.995	0.61	1.08	-	1	0	0	100%	0.9333
5LDS_NAG_B_1007	100%	67%	0.022	0.995	0.48	0.79	-	-	0	0	100%	0.9333
5O5D_NAG_A_601	100%	65%	0.022	0.994	0.32	0.99	-	1	0	0	100%	0.9333
6MUG_NAG_G_629	100%	76%	0.022	0.994	0.35	0.58	-	-	0	0	100%	0.9333
3PPS_NAG_B_760	100%	44%	0.028	0.993	0.57	1.57	-	3	0	0	100%	0.9333

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.